Skip to content

intravenous bolous of Nor epinephrine and Ephedrine in prevention of post spinal hypotension in cesarean section

Comparison of intravenous bolous of Nor epinephrine and Ephedrine in prevention of post spinal hypotension in cesarean section

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120915010841N17
Enrollment
100
Registered
2019-05-17
Start date
2019-05-15
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia in cesarean section. Single liveborn infant, delivered by cesarean

Interventions

Intervention 1: Intervention group: 5 µg of norepinephrine is injected immediately after spinal anesthesia. Intervention 2: Intervention group: The 10 mg ephedrine is injected immediately after spinal

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 46 Years

Inclusion criteria

Inclusion criteria: Satisfaction to participate in the project Pregnant women aged 18 to 46 Pregnant women who underwent cesarean section under spinal anesthesia

Exclusion criteria

Exclusion criteria: sensitivity to medications used Patients who have failed spinal anesthesia and undergo general anesthesia Lung disease, heart disease, asthma, fever, hypertension, preeclampsia and eclampsia, cardiac arrhythmia

Design outcomes

Primary

MeasureTime frame
Hypotension. Timepoint: Every two minutes to 10 minutes, then every 5 minutes to 15 minutes, then every 10 minutes until the end of the surgery. Method of measurement: Non-invasive blood pressure.

Secondary

MeasureTime frame
Nausea & vomiting. Timepoint: after delivery. Method of measurement: Observation.;New born Apgar. Timepoint: 1&5 minutes after delivery. Method of measurement: Apgar Score.;Headache. Timepoint: after delivery. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Manouchehrian

Hamedan University of Medical Sciences

manuchehriann@gmail.com+98 81 3827 7012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026